Clinical Trials List
2024-06-01 - 2028-03-31
Phase II
Recruiting7
ICD-10C68.0
Malignant neoplasm of urethra
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9189.3
Malignant neoplasm of urethra
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 無
- Chi-Shun Lien 無
- 蔡禮賢 無
- Hsi-Chin Wu 無
- Yi-Huei Chang 無
- Su-Peng Yeh 無
- Po-Fan Hsieh 無
- Yu-De Wang 無
- Chao-Hsiang Chang 無
- Chi-Rei Yang 無
- Po-Jen Hsiao 無
- 鄭富銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Lung Ke 無
- Tsu-Ming Chien 無
- 阮雍順 無
- Ching-Chia Li 無
- 曾漢儀 無
- Hsiang Ying Lee 無
- 張灝漢 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
375 participants
